Suraksha Diagnostic Stock Screener | Share Price & Fundamental Analysis
SURAKSHA
Healthcare Service Provider
Share Price NSE
₹261.98
▲
8.49 (3.35%)
Share Price BSE
₹261.00
▲
6.35 (2.49%)
Track Suraksha Diagnostic share price live with TickJournal's free stock screener.
Analyze Suraksha Diagnostic share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Suraksha Diagnostic Market Cap
₹1,355.66 Cr.
SURAKSHA P/E Ratio (TTM)
40.64
Suraksha Diagnostic P/B Ratio
5.71
EPS (TTM)
₹5.97
Dividend Yield
-
Debt to Equity
0.46
SURAKSHA 52 Week High
₹349.95
Suraksha Diagnostic 52 Week Low
₹227.95
Operating Margin
29.00%
Profit Margin
10.61%
SURAKSHA Revenue (TTM)
₹66.00
EBITDA
₹20.00
Net Income
₹7.00
Total Assets
₹334.00
Total Equity
₹210.00
Suraksha Diagnostic Share Price History - Stock Screener Chart
Screen SURAKSHA historical share price movements with interactive charts. Analyze price trends and patterns.
Suraksha Diagnostic Company Profile - Fundamental Screener
Screen Suraksha Diagnostic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SURAKSHA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE877V01027
Suraksha Diagnostic Balance Sheet Screener
Screen SURAKSHA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 334 | 300 | 281 | 0 | 171 | 173 |
| Current Assets | 47 | 72 | 68 | 0 | 27 | 28 |
| Fixed Assets | 223 | 212 | 195 | 0 | 119 | 128 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 81 | 82 | 87 | 0 | 20 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 210 | 179 | 156 | 0 | 126 | 120 |
| Share Capital | 10 | 9 | 9 | 0 | 9 | 9 |
| Reserves & Surplus | 201 | 171 | 147 | 0 | 118 | 111 |
Suraksha Diagnostic Income Statement Screener - Profit & Revenue Analysis
Screen Suraksha Diagnostic income statement and profit fundamentals.
Analyze SURAKSHA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Suraksha Diagnostic share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 66 | 74 | 80 | 78 | 56 | 62 | 68 | 60 | 53 | 61 | 53 |
| Expenses | 46 | 49 | 55 | 55 | 37 | 40 | 44 | 41 | 37 | 39 | 37 |
| EBITDA | 20 | 25 | 25 | 24 | 20 | 22 | 25 | 19 | 16 | 21 | 16 |
| Operating Profit % | 29.00% | 33.00% | 31.00% | 30.00% | 34.00% | 34.00% | 35.00% | 31.00% | 28.00% | 35.00% | 30.00% |
| Depreciation | 9 | 10 | 10 | 11 | 8 | 9 | 9 | 9 | 8 | 8 | 8 |
| Interest | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Profit Before Tax | 9 | 13 | 12 | 10 | 9 | 11 | 14 | 8 | 5 | 11 | 6 |
| Tax | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 2 | 1 | 3 | 2 |
| Net Profit | 7 | 9 | 9 | 7 | 6 | 8 | 10 | 6 | 4 | 8 | 5 |
| EPS | 1.42 | 1.80 | 1.73 | 1.44 | 1.22 | 1.49 | 1.94 | 1.18 | 1.17 | 2.44 | 0.87 |
Suraksha Diagnostic Cash Flow Screener - Liquidity Fundamentals
Screen SURAKSHA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 63 | 61 | 44 | 42 | 24 | 31 |
| Investing Activities | -40 | -35 | -21 | -44 | -28 | -20 |
| Financing Activities | -24 | -25 | -24 | 1 | 3 | -10 |
| Net Cash Flow | 0 | 0 | -1 | 0 | -1 | 1 |
Suraksha Diagnostic Shareholding Pattern Screener
See Suraksha Diagnostic shareholding pattern with promoter, FII, and DII holdings.
Check Suraksha Diagnostic promoter holding and ownership changes for SURAKSHA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jul | 2024-Nov | 2024-Dec |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.78% | 48.88% | 48.98% | 49.00% | 72.41% | 61.06% | 48.78% |
| FII Holding | 14.46% | 13.95% | 13.72% | 13.46% | 0.00% | 0.00% | 15.39% |
| DII Holding | 22.05% | 22.37% | 21.98% | 22.57% | 0.00% | 0.00% | 20.44% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.52% | 13.08% | 12.96% | 12.60% | 0.00% | 0.00% | 14.08% |
| Other Holding | 1.19% | 1.71% | 2.36% | 2.38% | 27.59% | 38.94% | 1.31% |
| Shareholder Count | 87,275 | 79,670 | 75,304 | 70,963 | 10 | 10 | 10 |
Suraksha Diagnostic Share Dividend Screener - Share Yield Analysis
Check Suraksha Diagnostic dividend history with payout and yield data.
View Suraksha Diagnostic dividend details including ex-dates and amounts for SURAKSHA stock.
Suraksha Diagnostic Stock Index Membership
See which indices include Suraksha Diagnostic stock.
Check SURAKSHA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY IPO
Suraksha Diagnostic Market Events Screener - Corporate Actions
Get Suraksha Diagnostic corporate actions including splits, bonuses, and buybacks.
Check Suraksha Diagnostic stock events that may affect SURAKSHA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -7.42% | ||
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 9.06% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.50% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -4.71% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 3.91% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 11.34% |
| 2024-12-20 | 2024-12-20 | Quarterly Result Announcement | NA | -0.81% |
Suraksha Diagnostic Competitors Screener - Peer Comparison
Screen SURAKSHA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 21,919 | 41.66 | 2,555 | 11.28% | 492 | 35.09 |
| Vijaya Diagnostic Centre | 9,293 | 59.48 | 700 | 23.06% | 144 | 33.11 |
| Metropolis Healthcare | 9,143 | 223.40 | 1,346 | 10.64% | 146 | 36.62 |
| Thyrocare Technologies | 5,592 | 42.11 | 702 | 20.80% | 91 | 32.37 |
| Nephrocare Health Services | 5,347 | 74.12 | 770 | 33.97% | 67 | 45.61 |
| Krsnaa Diagnostics | 1,906 | 23.95 | 743 | 16.70% | 78 | 32.85 |
| Suraksha Diagnostic | 1,356 | 40.64 | 256 | 15.11% | 31 | 45.20 |
| One Global Service Provider | 1,104 | 17.46 | 148 | 134.60% | 19 | 40.81 |
| 3B BlackBio DX | 1,103 | 18.92 | 112 | 28.72% | 48 | 42.27 |
| Sastasundar Ventures | 916 | 30.92 | 1,171 | -18.47% | -134 | 52.26 |
Suraksha Diagnostic Company Announcements - News Screener
Screen SURAKSHA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-06 | Closure of Trading Window | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-05 | Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2025 Along With The Limited Review Report. | - |
| 2026-02-05 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday 05 February 2026 | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-27 | Board Meeting Intimation for The Board Meeting To Be Held On Thursday 05 February 2026 | - |
| 2026-01-16 | Intimation Regarding Change In Name Of Statutory Auditor Of The Company Pursuant To Conversion Into LLP | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-22 | Closure of Trading Window | - |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |